Nanoscience is one of the most developed fields in today's world. Its applications cover examples in natural, physical, pharmacological, and chemical sciences, with a high impact on human advancement in the present and the future. The application of nanotechnologies includes several advantages, for example, the decrease of manufacturing costs, the development of new technologies based on new properties, and the mitigation of side effects on human and environmental health.
A stroke is a medical condition where poor blood flow causes the cell’s death because of a cerebrovascular or cardiovascular blockage. Strokes have been reported as one of the primary causes of death in 2019, with a 22% increase since the beginning of this century. This condition was responsible for 8.9 million deaths in 2019, with an expected increase, consequence of its relationship with the SARS-COV-2 (COVID19) virus¹. Its high impact in human health has pushed scientists to develop and improve technologies for the study and treatment of strokes, as well as the relationship between stroke and viral diseases^2-4. Current treatments for the disease have not overcome the medical limitations, where the administration times, drug efficiency, complex medical interventions, and secondary effects (such as haemorrhage) are liable for causing deaths among the treated people⁵. In this context, nanoscience concepts such as Lab-On-A-Chip technologies, controlled drug carrier transport, and micro-particle synthesis and manipulation can serve as a tool to overcome current challenges in stroke therapy. In this contribution, we will show how microfluidic technologies can have a great impact on this field enabling a controlled localization of clots as well as the study of their dissolution.